Healthcare Investment & Commercialization Leadership

Helping healthcare investors, portfolio companies, innovators, and strategic organizations accelerate commercialization, obtain funding, strengthen operations, build strategic partnerships, and create long-term enterprise value.

Understated modern boardroom interior — refined executive setting, subtle premium tone

Capital alone rarely determines success

Today, I selectively work with healthcare investors, venture firms, private equity groups, family offices, portfolio companies, founders, and strategic organizations that need experienced leadership to accelerate commercialization, strengthen operations, build strategic partnerships, lead investor relations and create enterprise value.

I am particularly interested in executive leadership, Operating Partner and Venture Partner roles, fractional executive engagements, board and advisory positions, and strategic collaboration opportunities.

Representative Experience Creating Enterprise Value

Representative organizations and initiatives from more than 35 years of leadership across MedTech, NeuroTech, Digital Health, Healthcare AI, commercialization, strategic partnerships, operations, and enterprise growth.

My Journey Through Medtech

A partial view of Gregg’s experience across MedTech, healthcare innovation, commercialization, transactions, and industry leadership.

  • ACS / Guidant Vascular (formerly Advanced Cardiovascular Systems, Eli Lilly) – Led and co-led numerous corporate development, transformation initiatives, commercialization and R&D efforts supporting next-generation interventional cardiology technologies; later part of Abbott's $27B acquisition of Guidant.

  • St. Francis Medical Technologies / Kyphon / Medtronic – Led R&D and cross-functional initiatives during rapid growth, contributing to technologies acquired by Kyphon ($725M) and later Medtronic ($3.9B).

  • Channel Medsystems (Cerene) – Co-Founder, VP Program Management, and investor in what became a $270M settlement agreement with Boston Scientific.

  • Drawbridge Health / Thorne Nutriceuticals – Led strategic partnerships and contract manufacturing scale-up, contributing to the company's subsequent eight-figure private equity exit.

  • Manifold Health – Helped launch an AI-native healthcare platform, supporting commercialization strategy, strategic partnerships, program management, Investor Relations, prior to and following the company launch at J.P. Morgan Healthcare Week (2026).

  • N-Spine - Acting Director of R&D, helping with company readiness for aquisition by Synthes for $45M

Gregg regularly contributes to industry forums, innovation programs, conferences, and professional discussions focused on medical technology, neurotechnology, healthcare innovation, commercialization, and growth.

Healthcare Commercialization and Portfolio Value Creation

An operating, advisory, and strategic partnership platform helping healthcare organizations and portfolio companies move from innovation to adoption, growth, and sustainable enterprise value.

Operating Capabilities

  • Executive Leadership

  • Commercialization Strategy

  • Portfolio Company Acceleration

  • Strategic Partnerships

  • Business Development

  • Operations and Program Leadership

  • Contract Mfg Ramp Up and Scale Up

  • Fundraising and Investor Relations

Where We Create Value

I help organizations reduce commercialization risk while increasing the probability of market adoption, strategic partnerships and long-term enterprise value.

Logo

Channel MedSystems

Co-Founder and Investor

Channel MedSystems: Take control of heavy periods with Cerene® Endometrial Cryotherapy — a 2½-minute, incision-free treatment with no anesthesia and minimal downtime.

Logo

AdviNOW Medical

Investor

AI Assistant that does everything from digital front door self scheduling and registration to decision support, scribe, and follow up.

Logo

Manifold Health AI

Investor and Strategic Advisor, (Former COO)

Precision Health Intelligence
Identify high-risk populations, coordinate interventions, and continuously measure outcomes through self-administered, virtually guided, blood testing, biological intelligence, and care management.

Logo

Reflection Sciences

Investor and Strategic Advisor

Reflection Sciences helps educators, families, and students understand, measure, and improve the cognitive skills needed to succeed in school, career, and life. Its science-backed tools focus on executive function, including attention and decision-making.

Explore a Strategic Leadership Opportunity

Gregg welcomes inquiries from healthcare investors, venture and private equity firms, family offices, portfolio companies, boards, founders, and strategic organizations seeking experienced leadership in commercialization, operations, partnerships, and enterprise growth.

Potential areas of collaboration include:

  • Executive leadership roles

  • Operating Partner and Venture Partner opportunities

  • Fractional executive and strategic advisory engagements

  • Board and advisory positions

  • Portfolio company commercialization and operating support

  • Strategic partnerships and business development

  • Investments

Have an executive, operating, investment, advisory, or strategic partnership opportunity to discuss?

Share a brief overview for Gregg’s review.

📞 Phone: 650-218-6459

✉️ Email: [email protected]

💼LinkedIn: https://www.linkedin.com/in/gregg-a-jackson/

🌐 Strategic Advisory and Investment Services
https://greggajackson.com/strategic-business-development

+1 (555) 019-2026

linkedin.com/in/gregg-a-jackson

© 2026 Gregg A. Jackson Family Office. All rights reserved.

Information presented on this website is for general informational purposes only and does not constitute an offer, solicitation, or investment advice.